Healthcare & Pharmaceuticals

Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine - gov't sources

1 minute read

LIMA, Jan 27 (Reuters) - Peru has given 'exceptional' approval for the import and use of 1 million COVID-19 vaccines from China's Sinopharm, two government sources told Reuters on Wednesday as the Andean nation grapples with a new wave of infections.

Register now for FREE unlimited access to Reuters.com
Reporting by Marco Aquino; Writing by Adam Jourdan

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters